Literature DB >> 11546678

Modulation of glucagon receptor expression and response in transfected human embryonic kidney cells.

T Ikegami1, A M Cypess, B Bouscarel.   

Abstract

The modulation of glucagon receptor (GR) expression and biological response was investigated in human embryonic kidney cell (HEK-293) clones permanently expressing the GR with different densities. The GR mRNA expression level in these clones was upregulated by cellular cAMP accumulation and presented a good correlation with both the protein expression level and the maximum number of glucagon binding sites. However, the determination of glucagon-induced cAMP accumulation in these cell lines revealed that the enhancement of receptor expression did not lead to a proportional increase in cAMP formation. Under these conditions, the maximum cAMP production induced by NaF and forskolin was not significantly different among selected clones, regardless of the receptor expression level. High receptor-expressing clones showed the greatest susceptibility for agonist-induced desensitization compared with clones with lower GR expression levels. The results of the present study suggest that the GR can recruit non-GR-specific desensitization mechanism(s). Furthermore, the partial inhibition or alteration of the overall cAMP synthesis pathway at the receptor level may be a necessary adaptive step for a cell in response to a massive increase in membrane receptor expression level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11546678     DOI: 10.1152/ajpcell.2001.281.4.C1396

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  5 in total

1.  Dual mode of glucagon receptor internalization: role of PKCα, GRKs and β-arrestins.

Authors:  Lada Krilov; Amy Nguyen; Teruo Miyazaki; Cecilia G Unson; Russell Williams; Norman H Lee; Susan Ceryak; Bernard Bouscarel
Journal:  Exp Cell Res       Date:  2011-10-06       Impact factor: 3.905

Review 2.  Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas.

Authors:  Melanie A Jackson; Nicholas Caputo; Jessica R Castle; Larry L David; Charles T Roberts; W Kenneth Ward
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

3.  Glucagon receptor recycling: role of carboxyl terminus, beta-arrestins, and cytoskeleton.

Authors:  Lada Krilov; Amy Nguyen; Teruo Miyazaki; Cecilia G Unson; Bernard Bouscarel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-11       Impact factor: 4.249

4.  PKC stimulated by glucagon decreases UT-A1 urea transporter expression in rat IMCD.

Authors:  Yuristella Yano; Adilson C Rodrígues; Ana C de Bragança; Lucia C Andrade; Antonio J Magaldi
Journal:  Pflugers Arch       Date:  2008-05-01       Impact factor: 3.657

5.  A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice.

Authors:  V K Bhat; B D Kerr; S Vasu; P R Flatt; V A Gault
Journal:  Diabetologia       Date:  2013-03-17       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.